[Federal Register Volume 72, Number 226 (Monday, November 26, 2007)]
[Notices]
[Page 65947]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-22963]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Intent To Grant an Exclusive License of a U.S. Government-Owned 
Patent

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7 
(a)(I)(i), announcement is made of the intent to grant an exclusive, 
royalty-bearing, revocable license to A Live-Attenuated Rift Valley 
fever virus as a licensed human vaccine to The University of Texas 
Medical Branch at Galveston, with its principal place of business at 
301 University Boulevard, Galveston, TX 77555.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-ZA-J, 504 Scott Street, Fort 
Detrick, Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For licensing issues, Dr. Paul Mele, 
Office of Research & Technology Assessment, (301) 619-6664. For patent 
issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808, both at 
telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Anyone wishing to object to the grant of 
this license can file written objections along with supporting 
evidence, if any, 15 days from the date of this publication. Written 
objections are to be filed with the Command Judge Advocate (see 
ADDRESSES).

Brenda S. Bowen,
Army Federal Register Liaison Officer.
 [FR Doc. E7-22963 Filed 11-23-07; 8:45 am]
BILLING CODE 3710-08-P